Newsroom

Biotech–Pharma Partnership: Tübingen-based biotech company Prime Vector Technologies has announced an exclusive licensing agreement with pharmaceutical company Boehringer Ingelheim centered on the…

The BioPharma Cluster South Germany is participating in a panel discussion at BPI Europe, which is taking place in Vienna from 27 to 30 April.

Rentschler Biopharma has a new Chief Operating Officer (COO).

The Laupheim-based CDMO Rentschler Biopharma is getting new leadership, with the CEO and COO leaving the company.

The successful joint series of events organised by the BioPharmaCluster South Germany and the Society for Biochemistry and Molecular Biology (GBM) will be continued.